| 1. |  3PBIOVIAN Turku, Finland (Biovian) / Pamplona, Spain (3P) - now pan-European | CDMO | CDMO - supports clients' pipelines from Discovery through Commercial | VIEW |
| 2. |  3PBIOVIAN Noáin (Navarra), Spain | CDMO | Commercial | VIEW |
| 3. |  4D Pharma plc Leeds, United Kingdom | Biotech | Preclinical to Phase II (at time of administration) | VIEW |
| 4. |  AGS Therapeutics Paris, France | Biotech | Preclinical | VIEW |
| 5. |  ARENSIA Exploratory Medicine Dusseldorf, Germany | CRO | Commercial | VIEW |
| 6. |  AbCellera Vancouver, Canada | Biotech | Phase 2 | VIEW |
| 7. |  Abcuro, Inc. Newton, Massachusetts, USA | Biotech | Phase 2/3 | VIEW |
| 8. |  | Biotech | Phase 3 | VIEW |
| 9. |  Abzena Cambridge, United Kingdom | CDMO | Commercial | VIEW |
| 10. |  Advanced Clinical Deerfield, Illinois, USA | CRO | Commercial | VIEW |
| 11. |  Affitech Copenhagen, Denmark (with R&D in Oslo, Norway and San Francisco, USA) | Biotech | Clinical | VIEW |
| 12. |  Agostino Gemelli University Hospital Rome, Italy | CRO | Phase 1-4 | VIEW |
| 13. |  Aico Worldwide Boston, USA | Digital Health | Commercial | VIEW |
| 14. |  Ajou University Suwon, South Korea | Biotech | Phase 3 | VIEW |
| 15. |  Akkodis Zurich, Switzerland | CRO | Commercial | VIEW |
| 16. |  Allucent Cary, North Carolina, USA | CRO | Commercial | VIEW |
| 17. |  Allygen Biosciences Shanghai, China | Biotech | Preclinical | VIEW |
| 18. |  Almac Group Craigavon, United Kingdom | CDMO | Discovery | VIEW |
| 19. |  Altasciences Laval, Quebec, Canada | CRO | Preclinical to Phase II (early-phase development) | VIEW |
| 20. |  Amgen Thousand Oaks, California, United States | Pharma | Discovery through Commercial | VIEW |
| 21. |  Anthem Biosciences Bangalore, India | CDMO | Commercial | VIEW |
| 22. |  Apellis Pharmaceuticals, Inc. Waltham, Massachusetts, USA | Biotech | Commercial | VIEW |
| 23. |  Applied Pathology Systems Worcester, Massachusetts, USA | CRO | Commercial | VIEW |
| 24. |  Applied Process Technology, Inc. (AP Tech) Elkton, Maryland, USA | CDMO | Commercial | VIEW |
| 25. |  Aprogen Seongnam-si, South Korea | Biotech | Commercial | VIEW |
| 26. |  Arcus Biosciences Hayward, United States | Biotech | Phase 3 | VIEW |
| 27. |  Artica Therapeutics Leiden, Netherlands | Biotech | Preclinical | VIEW |
| 28. |  AskGene Camarillo, California, United States | Biotech | Phase 3 | VIEW |
| 29. |  Assertio Holdings, Inc. Lake Forest, USA | Biotech | Commercial | VIEW |
| 30. |  Astellas Pharma Inc. Tokyo, Japan | Pharma | Discovery to Phase 3 | VIEW |
| 31. |  Atara Biotherapeutics, Inc. Thousand Oaks, California, USA | Biotech | Clinical | VIEW |
| 32. |  Aurigene Pharmaceutical Services Limited Bengaluru, India | CDMO | Commercial | VIEW |
| 33. |  AutoCruitment Atlanta, Georgia, USA | CRO | Commercial | VIEW |
| 34. |  Autolus Therapeutics London, United Kingdom | Biotech | Commercial + Phase 1/2 | VIEW |
| 35. |  BASF Ludwigshafen, Germany | Pharma | Commercial | VIEW |
| 36. |  BC Platforms Zurich, Switzerland | Digital Health | Commercial | VIEW |
| 37. |  Bangkok Dusit Medical Services (BDMS) Bangkok, Thailand | Pharma | Commercial | VIEW |
| 38. |  | Pharma | Discovery through Commercial | VIEW |
| 39. |  BenevolentAI London, United Kingdom | Biotech | Phase 1|Phase 2|Preclinical | VIEW |
| 40. |  | CDMO | Commercial | VIEW |
| 41. |  Binex Co., Ltd. Busan, South Korea | CDMO | Commercial | VIEW |
| 42. |  BioChain Institute Inc. Newark, California, USA | Diagnostics | Commercial | VIEW |
| 43. |  BioDuro-Sundia Irvine, USA | CRO | Commercial | VIEW |
| 44. |  BioMed Valley Discoveries Kansas City, Missouri, USA | Biotech | Clinical (Phase 1-2) | VIEW |
| 45. |  | Biotech | Phase 1-3 | VIEW |
| 46. |  Biocon Limited Bengaluru, India | Pharma | Commercial, Phase 3, Phase 2, Phase 1 | VIEW |
| 47. |  Bionorica SE Neumarkt in der Oberpfalz, Germany | Pharma | Commercial | VIEW |
| 48. |  BlueRock Therapeutics Cambridge, USA | Biotech | Phase 3 | VIEW |
| 49. |  Blueprint Medicines Cambridge, USA | Biotech | Commercial | VIEW |
| 50. |  Boehringer Ingelheim Ingelheim am Rhein, Germany (near Mainz and Frankfurt) | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 51. |  Boostimmune Seoul, South Korea | Biotech | Preclinical | VIEW |
| 52. |  Bristol Myers Squibb Princeton, New Jersey, United States | Pharma | Phase 1-3 and Commercial | VIEW |
| 53. |  | Digital Health | Commercial | VIEW |
| 54. |  CDR-Life Schlieren, Zurich, Switzerland | Biotech | Phase 1 | VIEW |
| 55. |  CEMKA Bourg-la-Reine, France | CRO | Commercial | VIEW |
| 56. |  CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland | Biotech | Phase 3 | VIEW |
| 57. |  CSL Limited Melbourne, Australia | Pharma | Commercial | VIEW |
| 58. |  CSL Limited (CSL Behring is the largest division) Melbourne, Australia (corporate); King of Prussia, USA (CSL Behring) | Pharma | Phase 1 through Commercial | VIEW |
| 59. |  Cadence Design Systems San Jose, USA | Digital Health | Commercial | VIEW |
| 60. |  Caldera Therapeutics Cambridge, USA | Biotech | Phase 1 | VIEW |
| 61. |  Calico Life Sciences South San Francisco, United States | Biotech | Phase 2 | VIEW |
| 62. |  | Biotech | Phase 1 - Phase 2 | VIEW |
| 63. |  Carelon Research Wilmington, Delaware, USA | CRO | Commercial | VIEW |
| 64. |  Cellares South San Francisco, USA | CDMO | Commercial | VIEW |
| 65. |  Celltrion Incheon, South Korea | Pharma | Commercial | VIEW |
| 66. |  Celon Pharma Łomianki, Poland | Biotech | Phase 3 | VIEW |
| 67. |  Center of Molecular Immunology (CIM) Havana, Cuba | Biotech | Commercial | VIEW |
| 68. |  Centre for Human Drug Research Leiden, Netherlands | CRO | Discovery | VIEW |
| 69. |  Centrexion Therapeutics Boston, Massachusetts, United States | Biotech | Phase 1-3 | VIEW |
| 70. |  Cerebras Systems Sunnyvale, USA | Digital Health | Commercial | VIEW |
| 71. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 72. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 73. |  Chiba University Chiba, Japan | Biotech | Phase 2 | VIEW |
| 74. |  China Medical University Hospital (CMUH) Taichung, Taiwan | Biotech | Phase 2 | VIEW |
| 75. |  Chong Kun Dang Pharmaceutical Corp. Seoul, South Korea | Pharma | Commercial | VIEW |
| 76. |  Choose Life Biotech SA Bellinzona, Switzerland | Biotech | Preclinical | VIEW |
| 77. |  Chugai Pharma Taiwan Ltd. Taipei, Taiwan | Pharma | Commercial | VIEW |
| 78. |  Chugai Pharmaceutical Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 79. |  Chung-Ang University Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 80. |  Cincinnati Children's Hospital Medical Center Cincinnati, USA | Biotech | Commercial | VIEW |
| 81. |  Circio Holding ASA Lysaker, Norway | Biotech | Phase 1/2 | VIEW |
| 82. |  ClearView Healthcare Partners Newton, USA | CRO | - | VIEW |
| 83. |  Clinical Horizons Research Inc. Leonia, New Jersey, USA | CRO | Commercial | VIEW |
| 84. |  Clinical Process Services (CPS) Dubai, United Arab Emirates | CRO | Commercial | VIEW |
| 85. |  Clinical Service Center (CSC) Suzhou, China | CRO | Commercial | VIEW |
| 86. |  Clinical2Digital San Diego, USA | Digital Health | Commercial | VIEW |
| 87. |  Covance Princeton, New Jersey, USA | CRO | N/A - Service provider, not drug developer | VIEW |
| 88. |  Coya Therapeutics, Inc. Houston, USA | Biotech | Phase 2 | VIEW |
| 89. |  Crixmor LLC Malvern, Pennsylvania, USA | Biotech | Discovery | VIEW |
| 90. |  | Biotech | Phase 1 | VIEW |
| 91. |  Cullinan Therapeutics Cambridge, USA | Biotech | Phase 3 | VIEW |
| 92. |  Cupperson London, United Kingdom | CRO | Self-funded | VIEW |
| 93. |  CuraTeQ Biologics Hyderabad, India | Biotech | Commercial | VIEW |
| 94. |  CuraVac Rixensart, Belgium | Biotech | Phase 1B (completed) | Phase 2 (in preparation) | VIEW |
| 95. |  Curadev Pharma Pvt Ltd Noida, India | Biotech | Phase 1 | VIEW |
| 96. |  Cytel Cambridge, Massachusetts, USA | CRO | N/A - Service Provider | VIEW |
| 97. |  | CRO | Service Provider | VIEW |
| 98. |  Cytiva Marlborough, Massachusetts, USA | MedTech | Commercial | VIEW |
| 99. |  CytoAgents Pittsburgh, USA | Biotech | Phase 2 | VIEW |
| 100. |  CytoDyn Inc Vancouver, Washington | Biotech | Phase 2 clinical | VIEW |
| 101. |  CytoImmune Therapeutics Duarte, USA | Biotech | Phase 1 | VIEW |
| 102. |  CytoSen Therapeutics Orlando (Winter Springs), Florida, USA | Biotech | Phase 2 | VIEW |
| 103. |  Cytonics Corporation Jupiter, Florida, USA | Biotech | Phase 2 | VIEW |
| 104. |  Cytonus Therapeutics Carlsbad, California, United States | Biotech | Phase 1 | VIEW |
| 105. |  Cytovance Biologics Oklahoma City, USA | CDMO | Commercial | VIEW |
| 106. |  Cytovia Therapeutics Aventura, Florida, USA | Biotech | Phase 1/2 | VIEW |
| 107. |  | Biotech | Phase 2 | VIEW |
| 108. |  DBV Technologies Châtillon, France | Biotech | Phase 3 | VIEW |
| 109. |  Daewoong Pharmaceutical Seoul, South Korea | Pharma | Commercial | VIEW |
| 110. |  Daiichi Sankyo Chuo, Tokyo, Japan | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 111. |  Dartmouth College Hanover, USA | Biotech | Phase 3 | VIEW |
| 112. |  Definitive Healthcare Framingham, USA | Digital Health | Commercial | VIEW |
| 113. |  Deloitte France Puteaux (Paris La Défense), France | CRO | Commercial | VIEW |
| 114. |  Delve-RW LLC Franklin, Massachusetts, USA | CRO | Commercial | VIEW |
| 115. |  Development Center for Biotechnology (DCB) Taipei, Taiwan | Biotech | Preclinical | VIEW |
| 116. |  Dizal Pharmaceutical Shanghai, China | Biotech | Commercial | VIEW |
| 117. |  Dolor Therapeutics, Inc. Chicago, USA | Biotech | Preclinical | VIEW |
| 118. |  Dr. Reddy's Laboratories Ltd. Hyderabad, India | Pharma | Commercial | VIEW |
| 119. |  Duality Biologics Shanghai, China | Biotech | Phase 3 | VIEW |
| 120. |  EEE Pharma Maharashtra, India | Biotech | Commercial | VIEW |
| 121. |  ELIQUENT Life Sciences Washington, DC, USA | CRO | Commercial | VIEW |
| 122. |  ENGEDI RX Roswell, Georgia, USA | CRO | Commercial | VIEW |
| 123. |  ETH Zürich Zurich, Switzerland | Biotech | Discovery | VIEW |
| 124. |  EVERSANA Chicago, Illinois, USA | CRO | Commercial | VIEW |
| 125. |  EY Global Delivery Services (GDS) London, United Kingdom | CRO | Late Stage | VIEW |
| 126. |  Ecolab Inc. Saint Paul, USA | Pharma | Commercial | VIEW |
| 127. |  Efficient Pharma Management Corp. (EffPha) Taipei City, Taiwan | CRO | Commercial | VIEW |
| 128. |  EirGenix, Inc. New Taipei City, Taiwan | CDMO | Commercial | VIEW |
| 129. |  Elanco Animal Health Indianapolis, USA | Pharma | Commercial | VIEW |
| 130. |  Eledon Pharmaceuticals Irvine, USA | Biotech | Phase 2 | VIEW |
| 131. |  Elevance Health Indianapolis, USA | Digital Health | Commercial | VIEW |
| 132. |  Eli Lilly and Company Indianapolis, Indiana, USA | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 133. |  Enanta Pharmaceuticals, Inc. Watertown, Massachusetts, USA | Biotech | Phase 1-2 clinical | VIEW |
| 134. |  Enlivex Therapeutics Ltd. Ness Ziona, Israel | Biotech | Phase 2 | VIEW |
| 135. |  | Biotech | Preclinical | VIEW |
| 136. |  Escientia Life Sciences Hyderabad, India | CDMO | Commercial | VIEW |
| 137. |  Escientia Life Sciences South Windsor, Connecticut, USA | CDMO | Commercial | VIEW |
| 138. |  EurimPharm Arzneimittel GmbH Saaldorf-Surheim, Germany | Biotech | Commercial | VIEW |
| 139. |  European Medicines BV Lelystad, Netherlands | CRO | Commercial | VIEW |
| 140. |  Everest Medicines Shanghai, China | Biotech | Commercial | VIEW |
| 141. |  Evernorth Health Services St. Louis, USA | Digital Health | Commercial | VIEW |
| 142. |  Evolution Health Group, LLC Pearl River, New York, USA | CRO | Commercial | VIEW |
| 143. |  Evopoint Biosciences Suzhou, China | Biotech | Commercial (NDA Stage) | VIEW |
| 144. |  Evotec SE Hamburg, Germany | Biotech | Commercial | VIEW |
| 145. |  Export-Import Bank of Korea Seoul, South Korea | Pharma | Commercial | VIEW |
| 146. |  | CDMO | Commercial | VIEW |
| 147. |  FFF Enterprises, Inc. Temecula, USA | CDMO | Commercial | VIEW |
| 148. |  FNCT Biotech Seongnam-si, South Korea | Biotech | Preclinical | VIEW |
| 149. |  | Pharma | Commercial | VIEW |
| 150. |  Fidelity Investments Boston, USA | Pharma | Commercial | VIEW |
| 151. |  Fishfa Biogenics Rajkot, India | Biotech | Commercial | VIEW |
| 152. |  Flagship Pioneering Cambridge, USA | Biotech | Discovery | VIEW |
| 153. |  Formation Bio New York, USA | Biotech | Phase 3 | VIEW |
| 154. |  Formycon AG Planegg-Martinsried, Germany | Biotech | Commercial | VIEW |
| 155. |  Fresenius Kabi Bad Homburg, Germany | Pharma | Commercial | VIEW |
| 156. |  Frontage Laboratories (Shanghai) Co., Ltd. Shanghai, China | CRO | Commercial | VIEW |
| 157. |  Frontier Medicines South San Francisco, USA | Biotech | Phase 1/2 | VIEW |
| 158. |  Fujifilm Diosynth Biotechnologies Morrisville, North Carolina, USA | CDMO | Commercial | VIEW |
| 159. |  Fusion Antibodies Belfast, Northern Ireland, United Kingdom | CRO | Discovery|Preclinical|Clinical (clients' projects) | VIEW |
| 160. |  G&L Scientific Marlow, United Kingdom | CRO | Commercial | VIEW |
| 161. |  Gene Oasis Singapore, Singapore | Biotech | Clinical | VIEW |
| 162. |  Genentech South San Francisco, California, United States | Biotech | Discovery through Commercial | VIEW |
| 163. |  Genmab Copenhagen, Denmark | Biotech | Commercial | VIEW |
| 164. |  Georgia Southern University Statesboro, USA | Biotech | Discovery | VIEW |
| 165. |  Gilead Sciences Foster City, California, United States | Pharma | Commercial | VIEW |
| 166. |  GlobalData Plc London, United Kingdom | Digital Health | Commercial | VIEW |
| 167. |  Google (Google DeepMind / Isomorphic Labs) London, United Kingdom | Biotech | Preclinical | VIEW |
| 168. |  Granite Bio Basel, Switzerland | Biotech | Phase 1 | VIEW |
| 169. |  Grünenthal Aachen, Germany | Pharma | Commercial | VIEW |
| 170. |  Guangzhou Cellprotek Pharmaceutical Guangzhou, China | Biotech | Phase 3 (Planning) | VIEW |
| 171. |  HBM Partners Zug, Switzerland | Biotech | Commercial | VIEW |
| 172. |  | CRO | Commercial | VIEW |
| 173. |  HCW Biologics Inc. Miramar, Florida, USA | Biotech | Phase 2 | VIEW |
| 174. |  HDS Formación Barcelona, Spain | Digital Health | Commercial | VIEW |
| 175. |  Halozyme Therapeutics San Diego, USA | Biotech | Commercial | VIEW |
| 176. |  Hansa Biopharma Lund, Sweden | Biotech | Commercial | VIEW |
| 177. |  Hanyang University Seoul, South Korea | Biotech | Phase 2 | VIEW |
| 178. |  Harbour BioMed Shanghai, China | Biotech | Phase 3 | VIEW |
| 179. |  | Pharma | Commercial | VIEW |
| 180. |  Hetero Healthcare Ltd Hyderabad, India | Pharma | Commercial | VIEW |
| 181. |  Hexal AG Holzkirchen, Germany | Pharma | Commercial | VIEW |
| 182. |  | MedTech | Commercial | VIEW |
| 183. |  Howard University Washington, D.C., USA | Biotech | Discovery | VIEW |
| 184. |  Huron Consulting Group Chicago, USA | CRO | Commercial | VIEW |
| 185. |  Hypha Discovery Ltd Abingdon, United Kingdom | CRO | Discovery | VIEW |
| 186. |  ICLOS-PDLC L'Hospitalet de Llobregat (Barcelona), Spain | CRO | N/A (Service Provider) | VIEW |
| 187. |  | CRO | Commercial | VIEW |
| 188. |  IKP Knowledge Park Hyderabad, India | CRO | Commercial | VIEW |
| 189. |  | Biotech | Phase 1/2 | VIEW |
| 190. |  IQVIA Durham, North Carolina, United States (Primary) / Danbury, Connecticut, United States (Secondary) | CRO | N/A - Service Provider | VIEW |
| 191. |  Idorsia Allschwil, Switzerland | Biotech | Commercial | VIEW |
| 192. |  Immundiagnostik AG Bensheim, Germany | Diagnostics | Commercial | VIEW |
| 193. |  Immuneel Therapeutics Bengaluru, India | Biotech | Commercial | VIEW |
| 194. |  Immunis, Inc. Irvine, California, USA | Biotech | Phase 1/2 | VIEW |
| 195. |  Immunocore Abingdon, United Kingdom | Biotech | Commercial | VIEW |
| 196. |  Immunophotonics Saint Louis, Missouri, USA | Biotech | Phase 2/3 | VIEW |
| 197. |  Immunovant, Inc. Durham, North Carolina, USA | Biotech | Phase 3 | VIEW |
| 198. |  Indian Immunologicals Limited Hyderabad, India | Biotech | Commercial | VIEW |
| 199. |  | CRO | Commercial | VIEW |
| 200. |  Insmed Incorporated Bridgewater, New Jersey, USA | Biotech | Commercial | VIEW |
| 201. |  Intas Pharmaceuticals Ltd. Ahmedabad, India | Pharma | Commercial | VIEW |
| 202. |  Intellia Therapeutics Cambridge, USA | Biotech | Phase 3 | VIEW |
| 203. |  Intrommune Therapeutics New York, USA | Biotech | Phase 1 | VIEW |
| 204. |  Inttl Advocare New Delhi, India | CRO | Commercial | VIEW |
| 205. |  IntuitionLabs San Jose, California, USA | Digital Health | Commercial | VIEW |
| 206. |  Ionis Pharmaceuticals, Inc. Carlsbad, California, United States | Biotech | Phase 1 through Commercial | VIEW |
| 207. |  Italfarmaco Group Milan, Italy | Pharma | Commercial | VIEW |
| 208. |  JOINN Laboratories Beijing, China | CRO | Commercial | VIEW |
| 209. |  JW Pharmaceutical Gwacheon, South Korea | Pharma | Commercial | VIEW |
| 210. |  Janux Therapeutics San Diego, California, USA | Biotech | Phase 1 | VIEW |
| 211. |  Jiayue Pharmaceutical Guangzhou, China | Biotech | Phase 3 | VIEW |
| 212. |  Johnson & Johnson New Brunswick, New Jersey, USA | Pharma | Commercial | VIEW |
| 213. |  Johnson & Johnson New Brunswick, New Jersey, USA | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 214. |  Jubilant Pharmova Limited Noida, India | Pharma | Phase 2 | VIEW |
| 215. |  Jubilant Therapeutics Bedminster, NJ, United States | Biotech | Phase I/II Clinical | VIEW |
| 216. |  Junshi Biosciences Shanghai, China | Biotech | Commercial | VIEW |
| 217. |  KM Biologics Co., Ltd. Kumamoto, Japan | Biotech | Commercial | VIEW |
| 218. |  KMK Consulting Inc. Morristown, New Jersey, USA | CRO | Commercial | VIEW |
| 219. |  KaliVir Immunotherapeutics Pittsburgh, Pennsylvania, USA | Biotech | Phase 1/1b Clinical | VIEW |
| 220. |  Kedrion Biopharma Barga, Italy | Biotech | Commercial | VIEW |
| 221. |  Keenova Therapeutics (formerly Endo Pharmaceuticals/Mallinckrodt Specialty Brands) Dublin, Ireland | Pharma | Commercial|Phase 1-3 | VIEW |
| 222. |  Khartis Therapeutics, Inc. San Diego, USA | Biotech | Discovery | VIEW |
| 223. |  Kin Master Produtos Químicos Passo Fundo, Brazil | CDMO | Commercial | VIEW |
| 224. |  Kinexum Harpers Ferry, USA | CRO | Commercial | VIEW |
| 225. |  Kiniksa Pharmaceuticals London, United Kingdom | Biotech | Commercial | VIEW |
| 226. |  Komtur Pharmaceuticals Freiburg, Germany | CRO | Commercial | VIEW |
| 227. |  Kowa Company, Ltd. Nagoya, Japan | Pharma | Commercial | VIEW |
| 228. |  Kubost Research Georgia, United States | CRO | - | VIEW |
| 229. |  | Pharma | Commercial | VIEW |
| 230. |  Kyung Hee University Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 231. |  | Biotech | Commercial | VIEW |
| 232. |  LG Business Research Seoul, South Korea | Biotech | Commercial | VIEW |
| 233. |  Labcorp Burlington, North Carolina, USA | Diagnostics | Commercial | VIEW |
| 234. |  Laboratoires El Kendi Algiers, Algeria | CDMO | Commercial | VIEW |
| 235. |  Laboratoires Servier Orléans, France | Pharma | Preclinical through Commercial | VIEW |
| 236. |  Level Biotechnology Inc. New Taipei City, Taiwan | CRO | Commercial | VIEW |
| 237. |  LiBo Pharma Corp. New Taipei City, Taiwan | Biotech | Phase 2/Phase 3 | VIEW |
| 238. |  Life Science Strategy Group Menlo Park, USA | CRO | Commercial | VIEW |
| 239. |  Lifespan (now Brown University Health) Providence, USA | Pharma | Commercial | VIEW |
| 240. |  | CDMO | Commercial | VIEW |
| 241. |  Luxembourg Institute of Health Strassen, Luxembourg | Biotech | Discovery | VIEW |
| 242. |  MARS Group Inc. Bloomington, Illinois, USA | CRO | Commercial | VIEW |
| 243. |  MK Bio Consultancy Oss, Netherlands | CRO | Commercial | VIEW |
| 244. |  MRH Regulatory Sciences San Francisco, USA | CRO | Commercial | VIEW |
| 245. |  MSD Rahway, New Jersey, USA | Pharma | Commercial | VIEW |
| 246. |  Maxis Clinical Sciences Edison, United States | CRO | Unfunded | VIEW |
| 247. |  | Biotech | Commercial/Phase 3 | VIEW |
| 248. |  Medac Pharm / medac GmbH Wedel, Germany (near Hamburg) | Pharma | Commercial|Phase 2|Preclinical | VIEW |
| 249. |  Medison Pharma Petah Tikva, Israel | Biotech | Commercial | VIEW |
| 250. |  Mega Lifesciences Bangkok, Thailand | Pharma | Commercial | VIEW |
| 251. |  Mentor Technical Group Caguas, Puerto Rico | CRO | Commercial | VIEW |
| 252. |  Merck & Co., Inc. Rahway, New Jersey, United States | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 253. |  Merck KGaA Darmstadt, Germany | Pharma | Phase 3 | VIEW |
| 254. |  Merck KGaA, Darmstadt, Germany Darmstadt, Germany | Pharma | Commercial | VIEW |
| 255. |  MetaQ Trials Tel Aviv, Israel | Digital Health | Commercial | VIEW |
| 256. |  MilliporeSigma Burlington, USA / Darmstadt, Germany | CDMO | Commercial | VIEW |
| 257. |  Miltenyi Biotec Bergisch Gladbach, Germany | Biotech | Commercial | VIEW |
| 258. |  | Biotech | Commercial | VIEW |
| 259. |  Mogam Institute for Biomedical Research Seoul, South Korea | Biotech | Discovery|Preclinical | VIEW |
| 260. |  Mubadala Bio Abu Dhabi, United Arab Emirates | CDMO | Commercial (Manufacturing & Distribution) | VIEW |
| 261. |  | Biotech | Commercial | VIEW |
| 262. |  | CRO | Commercial | VIEW |
| 263. |  NPDK Bioconsulting San Diego, California | CRO | Commercial | VIEW |
| 264. |  Nantong University Nantong, China | Biotech | Phase 3 | VIEW |
| 265. |  Navigator Medicines, Inc. Scotch Plains, New Jersey, USA | Biotech | Phase 2a (NAV-240), Phase 1 (NAV-242) | VIEW |
| 266. |  NextCure, Inc. Beltsville, Maryland, USA | Biotech | Phase 2 | VIEW |
| 267. |  Nexus Bio Sydney, Australia | Biotech | Commercial | VIEW |
| 268. |  Ninety One London, United Kingdom | Digital Health | Commercial | VIEW |
| 269. |  Novartis Basel, Switzerland | Pharma | Phase 2, Phase 3, Commercial | VIEW |
| 270. |  | CRO | Discovery through Phase IV | VIEW |
| 271. |  Null Hypothesis Hangzhou, China | Digital Health | Commercial | VIEW |
| 272. |  Nurix Therapeutics, Inc. San Francisco, USA | Biotech | Phase 1/2 | VIEW |
| 273. |  ONO PHARMA UK LTD London, United Kingdom | Pharma | Phase 1 through Commercial | VIEW |
| 274. |  ONO Pharmaceutical Osaka, Japan (Chuo-ku) | Pharma | Phase 1-Phase 3 | VIEW |
| 275. |  Oceanus Plus Beijing, China | Digital Health | Commercial | VIEW |
| 276. |  Odyssey Therapeutics Boston, MA, United States | Biotech | Phase 2 | VIEW |
| 277. |  Okklo Life Sciences Nijmegen, Netherlands | Biotech | Phase 1 | VIEW |
| 278. |  On/Off Therapeutics Paris, France | Biotech | Preclinical | VIEW |
| 279. |  Orchard Therapeutics London, United Kingdom | Biotech | Commercial | VIEW |
| 280. |  Oscotec Inc. Seongnam-si, South Korea | Biotech | Phase 3 | VIEW |
| 281. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | Pharma | Phase 1 through Commercial | VIEW |
| 282. |  Owkin New York, USA and Paris, France | Digital Health | Phase 1 | VIEW |
| 283. |  | Pharma | Commercial | VIEW |
| 284. |  PPD (Pharmaceutical Product Development) Wilmington, North Carolina, USA | CRO | Commercial | VIEW |
| 285. |  Parexel Raleigh, North Carolina, USA | CRO | Phase I-IV (as a CRO, Parexel manages client pipelines, not its own) | VIEW |
| 286. |  Partex NV Eschborn, Germany | Biotech | Phase 2 | VIEW |
| 287. |  Parvus Therapeutics South San Francisco, USA | Biotech | Phase 1/2 | VIEW |
| 288. |  PharmaBlock Sciences (Nanjing), Inc. Nanjing, China | CDMO | Commercial | VIEW |
| 289. |  PharmaLex Mannheim, Germany (Hans-Thoma-Straße 22, 68163 Mannheim) / Bad Homburg, Germany | CRO | N/A - Service Provider (not drug developer) | VIEW |
| 290. |  PharmaLex (now Cencora PharmaLex) Multiple global headquarters; main offices in Switzerland and US | CRO | Consulting/Support across all stages - Discovery through Phase 4 | VIEW |
| 291. |  PicnicHealth San Francisco, USA | Digital Health | Commercial | VIEW |
| 292. |  Piramal Pharma Limited Mumbai, India | CDMO | Commercial Manufacturing (primarily services other companies' pipelines) | VIEW |
| 293. |  PlasmaGen BioSciences Bengaluru (Chamrajpet), India | Biotech | Commercial/Manufacturing | VIEW |
| 294. |  Platinum Life Excellence Biotech Beijing, China | Biotech | Commercial | VIEW |
| 295. |  Policlinico Gemelli Rome, Italy | CRO | Commercial | VIEW |
| 296. |  Polpharma Starogard Gdański, Poland | CDMO | Commercial | VIEW |
| 297. |  Prana Biosciences Worcester, USA | Biotech | Preclinical | VIEW |
| 298. |  Precision Medicine Group Bethesda, USA | CRO | Commercial | VIEW |
| 299. |  Precision for Medicine Bethesda, Maryland, USA | CRO | Commercial | VIEW |
| 300. |  Process Automation Solutions (PA) Ludwigshafen, Germany / Greenville, SC, USA | CDMO | Commercial | VIEW |
| 301. |  Pyramid Laboratories, Inc. Costa Mesa, USA | CDMO | Commercial | VIEW |
| 302. |  Quell Therapeutics London, United Kingdom | Biotech | Phase 2 | VIEW |
| 303. |  Quest Diagnostics Secaucus, New Jersey, USA | Diagnostics | Commercial | VIEW |
| 304. |  | Biotech | Phase 2 | VIEW |
| 305. |  | Biotech | Phase 1 | VIEW |
| 306. |  RWS Group Chalfont St Peter, United Kingdom | CRO | Commercial | VIEW |
| 307. |  Rancho BioSciences San Diego, USA | CRO | - | VIEW |
| 308. |  Rho Durham, North Carolina, USA | CRO | Commercial | VIEW |
| 309. |  Ridgeline Discovery Basel, Switzerland | Biotech | Discovery|Preclinical|Phase 1|Phase 2 | VIEW |
| 310. |  | CRO | Commercial | VIEW |
| 311. |  | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 312. |  | Pharma | Commercial | VIEW |
| 313. |  Roche Holding AG (via businesspartner.roche.com portal) Basel, Switzerland | Pharma | Phase 1 through Commercial | VIEW |
| 314. |  Rondo Therapeutics Hayward, USA | Biotech | Phase 1 | VIEW |
| 315. |  STADA Arzneimittel AG Bad Vilbel, Germany | Pharma | Commercial | VIEW |
| 316. |  STADA Arzneimittel AG Bad Vilbel, Germany | Pharma | Commercial | VIEW |
| 317. |  STAR Therapeutics South San Francisco, CA 94080, USA | Biotech | Phase 3 | VIEW |
| 318. |  SYFM Co., Ltd. Seoul, South Korea | CDMO | Commercial | VIEW |
| 319. |  Saama Technologies Campbell, USA | Digital Health | Commercial | VIEW |
| 320. |  Sai Life Sciences Hyderabad, India | CDMO | Commercial | VIEW |
| 321. |  | Pharma | Commercial | VIEW |
| 322. |  Sandoz Group AG Basel, Switzerland | Pharma | Commercial | VIEW |
| 323. |  | Pharma | Preclinical through Phase 3 | VIEW |
| 324. |  Santa Ana Bio Alameda, USA | Biotech | Preclinical | VIEW |
| 325. |  Sartorius Göttingen, Germany | CDMO | Commercial | VIEW |
| 326. |  Scenic Biotech Amsterdam, The Netherlands | Biotech | Preclinical to IND-enabling | VIEW |
| 327. |  Selvita S.A. Krakow, Poland | CRO | Discovery | VIEW |
| 328. |  Senti Biosciences South San Francisco, California, USA | Biotech | Phase 1 | VIEW |
| 329. |  Shanghai Jeyou Pharmaceutical Co., Ltd. Shanghai, China (Pudong district) | Biotech | Preclinical to Phase 2 | VIEW |
| 330. |  Shionogi & Co., Ltd. Osaka, Japan | Pharma | Commercial | VIEW |
| 331. |  | Pharma | Commercial | VIEW |
| 332. |  Sopharma AD Sofia, Bulgaria | Pharma | Commercial | VIEW |
| 333. |  Southeastern Clinical Research Institute Augusta, USA | CRO | Commercial | VIEW |
| 334. |  Sun Yat-sen University Guangzhou, China | Biotech | Commercial | VIEW |
| 335. |  Swedish Orphan Biovitrum AB (Sobi) Stockholm, Sweden | Biotech | Commercial | VIEW |
| 336. |  Swiss Garnier Life Sciences Chennai, India | CDMO | Commercial | VIEW |
| 337. |  Syneos Health Morrisville, North Carolina, USA | CRO | Not applicable - Syneos Health supports client pipelines across all stages (Discovery to Commercial) | VIEW |
| 338. |  Synexa Life Sciences Leiden, Netherlands | CRO | Commercial | VIEW |
| 339. |  Syngene International Bengaluru, India | CRO | Commercial | VIEW |
| 340. |  TCG Lifesciences Pvt Ltd Kolkata, India | CRO | Discovery | VIEW |
| 341. |  TFS HealthScience Lund, Sweden | CRO | Commercial | VIEW |
| 342. |  TRG Ventures Hellerup, Denmark | Biotech | Phase 3 | VIEW |
| 343. |  TXinno Bioscience Inc. Yongin-si, South Korea | Biotech | Phase 1 | VIEW |
| 344. |  TYG Oncology Mansfield, Nottinghamshire, United Kingdom | Biotech | Phase 1 | VIEW |
| 345. |  Taiho Pharmaceutical Co., Ltd. Tokyo, Japan | Biotech | Commercial | VIEW |
| 346. |  Takeda Pharmaceutical Company Tokyo, Japan | Pharma | Phase 3 | VIEW |
| 347. |  Tanabe Pharma Corporation Osaka, Japan | Pharma | Commercial | VIEW |
| 348. |  Tata Consultancy Services Mumbai, India | CRO | Commercial | VIEW |
| 349. |  Tech Observer Paramus, New Jersey 07652, United States | CRO | Phase 1-Phase 4 support | VIEW |
| 350. |  Teva Pharmaceutical Industries Ltd. Tel Aviv, Israel | Pharma | Commercial | VIEW |
| 351. |  Teva Pharmaceutical Industries Ltd. Tel Aviv, Israel | Pharma | Commercial | VIEW |
| 352. |  Teva Pharmaceutical Industries Ltd. Tel Aviv, Israel | Pharma | Commercial | VIEW |
| 353. |  Thermo Fisher Scientific Waltham, Massachusetts, United States | CRO | Full spectrum - from drug discovery through Phase I-III and commercial | VIEW |
| 354. |  Tonix Pharmaceuticals Holding Corp. Chatham, New Jersey, USA | Biotech | Commercial | VIEW |
| 355. |  Toray Industries, Inc. Nihonbashi Mitsui Tower, 1-1, Nihonbashi-Muromachi 2-chome, Chūō, Tokyo, Japan | Pharma | Phase 1 to Phase 2 | VIEW |
| 356. |  Travalcon Scarborough, Canada | Digital Health | Commercial | VIEW |
| 357. |  TrialBlaze Wilmington, North Carolina, USA | CRO | Commercial | VIEW |
| 358. |  Trinity Life Sciences Waltham, USA | CRO | Commercial | VIEW |
| 359. |  U.S. Stem Cell, Inc. Sunrise, Florida, United States | Biotech | Clinical Development | VIEW |
| 360. |  UBE Corporation Tokyo, Japan | Pharma | Commercial | VIEW |
| 361. |  | Pharma | Commercial | VIEW |
| 362. |  University of California, Berkeley Berkeley, USA | Biotech | Discovery | VIEW |
| 363. |  University of Cincinnati Cincinnati, USA | Biotech | Commercial | VIEW |
| 364. |  University of Colorado Boulder Boulder, USA | Biotech | Discovery | VIEW |
| 365. |  University of Essex Colchester, United Kingdom | Biotech | Discovery | VIEW |
| 366. |  University of Wisconsin–Madison Madison, USA | Biotech | Commercial | VIEW |
| 367. |  Vaarunya Biolabs Bengaluru, India | CRO | Commercial | VIEW |
| 368. |  Vaxcyte San Carlos, California, USA | Biotech | Clinical (Phase 2 and Phase 3) | VIEW |
| 369. |  Viatris Canonsburg, Pennsylvania, United States | Pharma | Phase 1 to Commercial | VIEW |
| 370. |  | Biotech | Phase 3 | VIEW |
| 371. |  WEP Clinical Morrisville, USA | CRO | Commercial | VIEW |
| 372. |  Wisdomi Clarkdale, Arizona, USA | Biotech | Discovery | VIEW |
| 373. |  WriteSource Medical Pty Ltd North Sydney, Australia | CRO | Commercial | VIEW |
| 374. |  WuXi AppTec Shanghai, China | CRO | Commercial | VIEW |
| 375. |  WuXi Biologics Wuxi, China | CDMO | Commercial | VIEW |
| 376. |  X4 Pharmaceuticals Boston, USA | Biotech | Commercial | VIEW |
| 377. |  Xencor, Inc. Pasadena, California, USA | Biotech | Phase 1/2 | VIEW |
| 378. |  Xilio Therapeutics Waltham, Massachusetts | Biotech | Phase 2 | VIEW |
| 379. |  Yasham Specialty Ingredients Pvt Ltd Mumbai, India | CDMO | Commercial | VIEW |
| 380. |  Yuhan Corporation Seoul, South Korea | Biotech | Commercial | VIEW |
| 381. |  | CRO | Commercial | VIEW |
| 382. |  Zai Lab Shanghai, China and Cambridge, MA, USA | Biotech | Commercial | VIEW |
| 383. |  Zuellig Pharma Singapore, Singapore | Pharma | Commercial | VIEW |
| 384. |  Zydus Lifesciences Limited Ahmedabad, India | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 385. |  arGenX (argenx) Amsterdam, Netherlands | Biotech | Phase 1 through Commercial | VIEW |
| 386. |  epiVeris Steamboat Springs, Colorado | Digital Health | - | VIEW |
| 387. |  | CDMO | Commercial | VIEW |
| 388. |  | Digital Health | Commercial | VIEW |